Intellia Therapeutics, Inc.
Ticker: 1652130
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 7.66-49.1% | 15.05+9.2% | 13.78-3.3% | 14.25-14.3% | 16.63+82.5% | 9.11+30.9% | 6.96-76.0% | 28.94 |
| Total Income | 7.66-49.1% | 15.05+9.2% | 13.78-3.3% | 14.25-14.3% | 16.63+82.5% | 9.11+30.9% | 6.96-76.0% | 28.94 |
| EXPENSES | ||||||||
| Expenditure | 120.42+4.2% | 115.58-7.7% | 125.26+0.8% | 124.24-9.6% | 137.43-10.7% | 153.88+5.4% | 146.00+2.1% | 142.94 |
| PROFIT | ||||||||
| Net Profit | -106.63-10.8% | -96.23+5.0% | -101.32-0.1% | -101.26+11.4% | -114.33+15.8% | -135.71+7.7% | -146.98-36.8% | -107.44 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.80+1.2% | -0.81+12.0% | -0.92+6.1% | -0.98+10.9% | -1.10+17.9% | -1.34+11.8% | -1.52-35.7% | -1.12 |
Corporate Events
Board MeetingNTLA
20269Jun
Board Meeting
Annual Meeting of Stockholders to elect Class I directors, r…
SEC Filing ↗